The US administration's strategy to reduce drug prices may lead pharmaceutical companies to review how they launch and negotiate new treatments in Europe. Portugal, which uses prices from other European countries as a reference, may also feel the effects of this pressure.
Pharmaceutical companies may adjust their prices in Europe to compensate for potential losses in the North American market, if Trump's measures result in lower prices in the United States. This means medications could become more expensive in Portugal and other European countries.
Portugal uses a reference system that compares medication prices with those practiced in other European countries. If those countries register increases in drug prices, Portugal may be affected by that rise.
Experts warn that the consequences of this policy may take some time to manifest, but that the impact on medication prices in Portugal is a real possibility given changes in the global pharmaceutical market.
